Related Experiment Videos
Effect of aspirin intake on bleeding during cataract surgery
E I Assia1, T Raskin, I Kaiserman
1Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba, Israel.
Journal of Cataract and Refractive Surgery
|October 13, 1998
Summary
Chronic aspirin use does not significantly increase bleeding during cataract surgery. Discontinuing aspirin before surgery is generally not necessary, offering a safer approach for patients.
Area of Science:
- Ophthalmology
- Cardiology
- Pharmacology
Background:
- Aspirin is widely used for thromboembolic event prevention.
- Its impact on intraoperative bleeding in cataract surgery requires clarification.
Purpose of the Study:
- To investigate the association between chronic aspirin intake and intraoperative bleeding during cataract surgery.
- To evaluate the effect of discontinuing aspirin before surgery on bleeding complications.
Main Methods:
- A study involving 61 patients undergoing cataract surgery and taking aspirin.
- Patients were divided into three groups: continuous aspirin, cessation for 2-5 days, and cessation for 7-10 days.
- Coagulation parameters, questionnaires, and follow-up were assessed.
Main Results:
- No significant differences in coagulation tests or intraoperative bleeding were observed among the groups.
- While diathermy was used more in the aspirin continuation group, bleeding was manageable.
- Discontinuing aspirin did not impact the intraoperative course or postoperative outcomes.
Conclusions:
- Chronic aspirin intake is not linked to significant intraoperative bleeding in cataract surgery.
- Routine discontinuation of aspirin before cataract surgery is typically not indicated.
- Clear corneal phacoemulsification is a beneficial technique for patients on antiplatelet therapy.